MedPath

Effect of Potato Fiber on Appetite and Fecal Fat Excretion

Not Applicable
Completed
Conditions
Fecal Fat Increased
Obesity
Appetite
Interventions
Dietary Supplement: FiberBind
Dietary Supplement: Placebo
Dietary Supplement: RG-I fiber
Registration Number
NCT02957318
Lead Sponsor
University of Copenhagen
Brief Summary

Results have indicated that some dietary fibers increase fecal fat excretion and particularly viscous fibers suppress appetite sensation and reduce energy intake. Both these effects may contribute to body weight management.

Aim: The aim of the study is to investigate the potential of 3-weeks daily intake of potato pulp (FiberBind), rhamnogalacturonan I isolated potato fiber (RG-I) vs. a low-fiber control (placebo) on satiety and fecal fat excretion in healthy adults. Furthermore, a number of secondary endpoints are investigated.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
18
Inclusion Criteria
  • Healthy Men
  • BMI between 18.5 and 27.0 kg/m2
  • Age 20-40 years
Exclusion Criteria
  • Intake of potatoes with main meals more frequent than 4 times per week
  • Chronic diseases (known diabetes, cardiovascular disease, irritable bowels disease, colitis ulcerosa, crohn disease, or other chronic diseases which could affect the results of the present study)
  • Gluten allergy
  • Use of daily prescription medicine (mild analgesics are allowed)
  • Use of lipid-lowering agents (e.g. Becel, HUSK)
  • Use of food supplements of relevance to the study (such as pre- and probiotics)
  • Irregular intake of vitamin /mineral supplements (two weeks prior to and during the entire study period)
  • Smoking
  • Elite athletes (>10 hours of strenuous physical activity per week)
  • Blood donation (<1 month before study commencement and during study period)
  • Participation in other clinical studies (<1 month before study commencement and during study period)
  • Inability (physically or psychologically) to comply with the procedures required by the protocol judged by the Investigator

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
FiberBindFiberBind-
PlaceboPlacebo-
RG-I fiberRG-I fiber-
Primary Outcome Measures
NameTimeMethod
Subjective appetite sensationsAssessed on 3-hour meal test on last day of the 21-day intervention periods

Assessed by visual analogue scales (VAS)

Fecal fat excretionBased on total feces collection the last 3 days of the 21-day intervention periods
Secondary Outcome Measures
NameTimeMethod
Gut microbiotaMeasured in a fresh feces sample from day 19-21 of the intervention periods
Gastrointestinal symptoms (questionnaire)on day 1, 7, 14 and 22 of the 21-day intervention periods
Blood pressureup to 21-day intervention periods
Breath hydrogenup to 21-day intervention periods
Body weightup to 21-day intervention periods
Ad libitum energy intakeAssessed 3 hours after intake of the test meal on last day of the 21-day intervention periods
Fecal energy excretionMeasured based on total feces collection the last 3 days of the 21-day intervention periods
Insulin and glucoseMeasured before and after the 21-day intervention periods, and every 30 minutes during the 3-hour meal test on last day of the 21-week intervention periods
Gut permeability markerMeasured before and after the 21-day intervention periods
Blood lipids (total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides)Measured before and after the 21-day intervention periods
Gastric emptying rate (w. paracetamol)Measured every 30 minutes during the 3-hour meal test on last day of the 21-day intervention periods

Trial Locations

Locations (1)

University of Copenhagen, Department of Nutrition, Exercise and Sports

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath